Elanco, Lilly’s animal health division, has made a one-time offer to acquire the animal health business of Janssen Pharmaceutica NV, a Johnson & Johnson company. Janssen’s animal health business, headquartered in Beerse, Belgium, is focused on targeting disease segments in companion animals and livestock, with special emphasis on swine and poultry. Should the deal close, Elanco would obtain a portfolio of about 50 marketed animal health products, as well as the transfer of Janssen’s anim...